China Shifts Drug Recall Burden To Manufacturers In Move To Increase Accountability
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State FDA launched a new nationwide drug recall system Dec. 10, with an aim to set up an effective cooperative system between the government and pharmaceutical companies, and encourage them to recall unsafe drugs voluntarily